During the last decade, treatment protocols have changed for patients with ileocolic Crohn's disease. Anti‐tumour necrosis factor (anti‐TNF) has become part of standard medical treatment, usually in a step‐up approach.… Click to show full abstract
During the last decade, treatment protocols have changed for patients with ileocolic Crohn's disease. Anti‐tumour necrosis factor (anti‐TNF) has become part of standard medical treatment, usually in a step‐up approach. The aim was to analyse if improved medical treatment has resulted in more limited ileocolic resections and a longer interval between diagnosis and surgery.
               
Click one of the above tabs to view related content.